HiberGene Diagnostics products

Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are among the most frequently transmitted sexually transmitted infections (STIs). It is estimated that 146 million people acquire CT and 51 million people acquire NG annually worldwide. Nucleic acid amplification tests (NAATs) are now recommended by NICE, European and CDC guidelines due to superior sensitivity, specificity and speed. It has been reported that more than 75% of CT/NG negative patients receive antibiotics unnecessarily while awaiting results. Reports show that up to 30% of patients are overtreated and up to 40% are undertreated leading to medical complications and increased antibiotic resistance.

HG Meningococcus – the only test on the market to painlessly screen young children for the most common cause of bacterial meningitis direct from throat swabs, in addition to traditional invasive sample types. Over 1.2 million cases of bacterial meningitis occur annually¹. Neisseria meningitidis, also known as meningococcus, causes up to 50% of bacterial meningitis cases in young children¹. Meningococcal infection is characterised by a rapid onset, difficult clinical diagnosis and high mortality (up to 50%) and morbidity rates (10%)². Highly ambiguous symptoms cause up to 50% of cases to be missed by GPs in the 24hrs before admission³.

Pneumo/Meningo Combo – improve patient outcomes and reduce unnecessary antibiotics and isolation costs with a simple and accurate molecular test. Neisseria meningitidis and Streptococcus pneumoniae cause up to 87% of bacterial meningitis cases in young children and adults¹. Bacterial meningitis is an aggressive disease with non-specific symptoms making it inherently difficult to diagnose. The disease is responsible for over 1.2 million cases and 170,000 deaths annually worldwide². Survivors may suffer severe, lifelong disabilities³.

Group B Streptococcus (GBS) – the only test for mother and baby. Saving time and saving money. Group B Streptococcus (GBS) is carried by 20-30% of pregnant women who risk transmitting the bacteria to the baby during birth, GBS is the leading cause of severe neonatal infection with high mortality (10%) and morbidity rates (20%)¹, Recent CDC and European guidelines recommend testing during labour using a rapid real time test to optimise antibiotic prophylaxis and prevent GBS infection²’³, Intrapartum testing is the only time that gives 100% certainty of GBS status, and can save up to 6$ per birth4

HiberGene’s PCR Adapt COVID-19 RT-qPCR is a CE marked multi-target SARS-CoV-2 test for nasopharyngeal (NP), oropharyngeal (OP) and anterior nasal swabs. This single tube assay is validated for both direct sample testing and manual/automated extraction.